A Phase 3, Multicenter, Multinational, Randomized,Open-Label,Parallel-Arm Study of Avelumab(MSB0010718C) Plus Best Supportive
|Effective start/end date||4/21/16 → 12/31/22|
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.